U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21)

Funding Agency:
National Institutes of Health

The purpose of the U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer program is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Russian researchers in the areas of cancer biology, prevention, early detection, diagnosis, and treatment as well as the physical and chemical sciences and engineering in cancer biology, nanotechnology, and radiation epidemiology.  

Application Due Date(s):  November 4, 2016

RFA-CA-16-015 Expiration Date November 5, 2016

Agency Website

Eligibility Requirements

The PD(s)/PI(s) must be from a U.S. institution.

Amount

$300,000

Amount Description

Application budgets are limited to $100,000 annually in direct costs over a 3-year period.  

Funding Type

Grant

Eligibility

Faculty

Category

Engineering and Physical Sciences
International Opportunities
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

November 4, 2016